Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols:: Dual Na+ and Ca2+ channel blockers with reduced affinity for dopamine D2 receptors

被引:25
作者
Annoura, H [1 ]
Nakanishi, K [1 ]
Uesugi, P [1 ]
Fukunaga, A [1 ]
Imajo, S [1 ]
Miyajima, A [1 ]
Tamura-Horikawa, Y [1 ]
Tamura, S [1 ]
机构
[1] Suntory Inst Biomed Res, Shimamoto, Osaka 6188503, Japan
关键词
D O I
10.1016/S0968-0896(01)00288-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel 4-arylpiperidines and 4-aryl-4-piperidinols (2a-f, 3a f and 4a-f) wits synthesized and evaluated for blocking effects on both neuronal Na+ and T-type Ca2+ channels and binding affinity for dopamine D-2 receptors. Most or the compounds blockaded both ion channels with potency greater than or equal to flunarizine Ia which was adopted as a reference standard. In addition, these compounds had significantly reduced affinity for dopamine D-2 receptors which is common in this class of structure. Compounds 2a-f, 3a-f and 4a-f exhibited potent anticonvulsant effects following systemic (ip) administration on audiogenic seizures in DBA/2 mice, indicating their excellent brain permeability. The neuroprotective activity of 2a, 3a and 4a was also assessed in a transient middle cerebral artery Occlusion (MCAO) model. These Compounds significantly reduced neuronal damage without affecting ischemic hyperthemia, while flunarizine Ia produced only minor reductions. In particular. 4a had 1.7-fold the potency in this MCAO model but only 1/20 the affinity for dopamine D-2 receptors of 1a. The Superposition of 2a, 3a and 4a on the basis of analyses of systematic conformation and similar structure has revealed that the cinnamyl, phenacyl and phenoxy-propanol groups are likely to be structurally and biologically equivalent. Moreover, the Superposition of 2a and 2f shows that diphenyl ether and biphenyl groups occupy a similar space, suggesting that both groups act as a bioisostere for the blockade of ion channels: however, this is not the case for dopamine D-2 receptors since only biphenyl Compounds such as 2f had high affinity similar to flunarizine Ia. Compound 4a (SUN N5030) has a good pharmacological profile and may be Useful in the alleviation and treatment or ischemic diseases. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:371 / 383
页数:13
相关论文
共 37 条
[1]   EFFECT OF GLUCOSE AND PYRUVATE METABOLISM ON MEMBRANE-POTENTIAL IN SYNAPTOSOMES [J].
AIUCHI, T ;
MATSUNAGA, M ;
DAIMATSU, T ;
NAKAYA, K ;
NAKAMURA, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 771 (02) :228-234
[2]   COMPARATIVE PROTECTIVE EFFECTS OF NICARDIPINE, FLUNARIZINE, LIDOFLAZINE AND NIMODIPINE AGAINST ISCHEMIC-INJURY IN THE HIPPOCAMPUS OF THE MONGOLIAN GERBIL [J].
ALPS, BJ ;
CALDER, C ;
HASS, WK ;
WILSON, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :877-883
[3]   A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects [J].
Annoura, H ;
Nakanishi, K ;
Uesugi, M ;
Fukunaga, A ;
Miyajima, A ;
Tamura-Horikawa, Y ;
Tamura, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (20) :2999-3002
[4]   NEW ANTI-ISCHAEMIC DRUGS - CYTOPROTECTIVE ACTION WITH NO PRIMARY HEMODYNAMIC-EFFECTS [J].
BODDEKE, E ;
HUGTENBURG, J ;
JAP, W ;
HEYNIS, J ;
VANZWIETEN, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (10) :397-400
[5]   Calcium signalling: a historical account, recent developments and future perspectives [J].
Brini, M ;
Carafoli, E .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (03) :354-370
[6]   THE EFFECT OF LIFARIZINE (RS-87476), A NOVEL SODIUM AND CALCIUM-CHANNEL MODULATOR, ON ISCHEMIC DOPAMINE DEPLETION IN THE CORPUS STRIATUM OF THE GERBIL [J].
BROWN, CM ;
CALDER, C ;
ALPS, BJ ;
SPEDDING, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :175-177
[7]  
CARTER PA, 1992, Patent No. 494717
[8]  
CHOI DW, 1995, TRENDS NEUROSCI, V18, P58
[9]   THE SYNTHESIS OF NOVEL PROSTAGLANDIN ANALOGS VIA CYCLOADDITION REACTIONS [J].
COLLINGTON, EW ;
FINCH, H ;
MONTANA, JG ;
TAYLOR, RJK .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1990, (07) :1839-1846
[10]   EXTRAPYRAMIDAL SYMPTOMS ASSOCIATED WITH CALCIUM-CHANNEL BLOCKERS [J].
DANIEL, JR ;
MAURO, VF .
ANNALS OF PHARMACOTHERAPY, 1995, 29 (01) :73-75